Sarah Colman

Publications (5)

Economic Burden of Checkpoint Inhibitor Immunotherapy for the Treatment of Non-Small Cell Lung Cancer in US Clinical Practice.

Clinical therapeutics
Avec: Mary K Nesline , Tyler Knight , Sam Colman , Kayshap Patel

Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic.

Expert review of pharmacoeconomics & outcomes research
Avec: Fulton F Velez , Sam Colman , Laura Kauffman , Charles Ruetsch , Kathryn Anastassopoulos

Pilot study of oral fluid and plasma meropenem and piperacillin concentrations in the intensive care unit.

Clinica chimica acta; international journal of clinical chemistry
Avec: Sofie Colman , Sofie Dhaese , Veronique Stove , Jan J De Waele , Alain G Verstraete

The impact of COVID-19 on antipsychotic prescriptions for patients with schizophrenia in Australia.

The Australian and New Zealand journal of psychiatry
Avec: Steve Kisely , Dante Dangelo-Kemp , Mark Taylor , Dennis Liu , Simon Graham , Jodie Hartmann , Sam Colman

Real-world changes in US health system hospital-based services following treatment with a prescription digital therapeutic for opioid use disorder.

Hospital practice (1995)
Avec: Fulton F Velez , Sam Colman , Laura Kauffman , Kathryn Anastassopoulos , Sean Murphy , Yuri Maricich

Réseau de co-auteurs

Sam Colman 4 collaborations
Fulton F Velez 2 collaborations
Laura Kauffman 2 collaborations
Kathryn Anastassopoulos 2 collaborations
Mary K Nesline 1 collaboration
Tyler Knight 1 collaboration
Kayshap Patel 1 collaboration
Charles Ruetsch 1 collaboration
Sofie Colman 1 collaboration
Sofie Dhaese 1 collaboration
Veronique Stove 1 collaboration
Jan J De Waele 1 collaboration
Alain G Verstraete 1 collaboration
Steve Kisely 1 collaboration
Dante Dangelo-Kemp 1 collaboration
Mark Taylor 1 collaboration
Dennis Liu 1 collaboration
Simon Graham 1 collaboration
Jodie Hartmann 1 collaboration
Sean Murphy 1 collaboration
Yuri Maricich 1 collaboration